Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2010
08/26/2010WO2010056040A3 Novel erythropoietin conjugates bonded with a biocompatible polymer
08/26/2010US20100217050 For pegylation of biodrugs such as proteins; end groups etherified with acetylenic group
08/26/2010US20100217045 Composition to enhance the bioavailability of curcumin
08/26/2010US20100216895 Food grade colouring agent
08/26/2010US20100216894 Novel compounds prepared by adding an oxetane derivative to an alcohol
08/26/2010US20100216729 Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts
08/26/2010US20100216714 Natriuretic compounds, conjugates, and uses thereof
08/26/2010US20100216692 Acidic Insulin Preparations Having Improved Stability
08/26/2010US20100215833 Coating for medical device and method of manufacture
08/26/2010US20100215760 Intrinscially fluorescent carbon nanospheres and a process thereof
08/26/2010US20100215754 Delivery System for Functional Compounds
08/26/2010US20100215753 Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
08/26/2010US20100215749 TEMPERATURE- AND pH-RESPONSIVE POLYMER COMPOSITIONS
08/26/2010US20100215747 Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
08/26/2010US20100215734 Pharmaceutical compositions
08/26/2010US20100215719 Polyarylates for drug delivery and tissue engineering
08/26/2010US20100215705 Use of Colloidal Clays for Sustained Release of Active Ingredients
08/26/2010US20100215685 Acyl pseudodipeptides which carry a functionalized auxiliary arm
08/26/2010US20100215576 Diagnosis and treatment of neuroectodermal tumors
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010CA2789515A1 Treatment of chronic inflammatory conditions
08/26/2010CA2767752A1 Improved anti-serum albumin binding variants
08/26/2010CA2753052A1 Pressure sensitive adhesive composition and pressure sensitive adhesive tape
08/26/2010CA2752902A1 Synthetic diblock copolypeptide hydrogels for use in the central nervous system
08/26/2010CA2752805A1 Formulation comprising drospirenone for subcutaneous or intramuscular administration
08/26/2010CA2752373A1 Glutathione-based drug delivery system
08/26/2010CA2750477A1 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists
08/26/2010CA2745657A1 Extended length botulinum toxin formulation for human or mammalian use
08/26/2010CA2729593A1 B7-h3 as a biomarker for diagnosing the progression and early lymph node metastasis of cancer
08/25/2010EP2221334A1 Method for chemically modifying biopolymer or polypeptide
08/25/2010EP2221317A2 PEGylated single domain antibodies (dAb)
08/25/2010EP2221062A1 Novel adjuvant
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2219679A1 Cross-linked hydrogel containing an active substance
08/25/2010EP2219678A2 Nanoparticles of therapeutic agents having low water solubility
08/25/2010EP2219677A1 Preparations, methods and kits useful for treatment of cough
08/25/2010EP2219676A1 Quarternization of the additive amino alkyl methacrylate copolymer e for improving permeability and solubility of pharmaceuticals
08/25/2010EP2219675A1 Formulations for taci-immunoglobulin fusion proteins
08/25/2010EP2219665A1 Parathyroid hormone formulations and uses thereof
08/25/2010EP2219651A1 Oral compositions of abt-263 for treating cancer
08/25/2010EP2219638A2 Lipoxin a4 protection for retinal cells
08/25/2010EP2219624A2 Pharmaceutical formulations
08/25/2010EP2219623A1 Pharmaceutical dosage form comprising a liquid or flowable core composition
08/25/2010EP2219616A2 Lyophilized pharmaceutical composition with improved stability containing taxane derivatives, and method of manufacturing the same
08/25/2010EP2219614A1 Pharmaceutical composition of orlistat
08/25/2010EP2219609A2 Immuno-modulatory composition
08/25/2010EP2219608A1 Self solidifying bioerodible barrier implant
08/25/2010EP2219607A1 Lh liquid formulations
08/25/2010EP2219604A2 Biomaterial for the controlled delivery of ingredients
08/25/2010EP2219603A1 Transdermal delivery system
08/25/2010EP2219601A2 Non-aqueous water-miscible materials as vehicles for drug delivery
08/25/2010EP2219599A2 Clonidine formulations in a biodegradable polymer carrier
08/25/2010EP1789091B1 Prodrugs containing novel bio-cleavable linkers
08/25/2010EP1637531B1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
08/25/2010EP1594436B1 Mutated neublastin
08/25/2010EP1541161B1 Tablet composition containing chinese orthodox medicine extract and process for producing the same
08/25/2010EP1474109B1 Use of synthetic inorganic nanoparticles as carriers for ophthalmic drugs
08/25/2010EP1406593B1 Biodegradable polymer compositions, compositions and uses related thereto
08/25/2010EP1385857B1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
08/25/2010EP1324755B1 Pharmaceutical solutions of modafinil compounds
08/25/2010EP1299494B1 Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
08/25/2010EP1263721B1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
08/25/2010EP1181047B9 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
08/25/2010CN1977972B Anti tumour drug oral colon targeting preparation and its preparing method
08/25/2010CN1970084B Hydrotalcite-like vesicle compounds and method for preparing same
08/25/2010CN1969847B Pharmaceutical composition
08/25/2010CN1879875B Preparations stabilized over long time
08/25/2010CN1638748B Taste-masked film-type or wafer-type medicinal preparation
08/25/2010CN101815724A aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
08/25/2010CN101815573A Method of producing emulsion or dispersion and food, skin external preparation and drug containing emulsion or dispersion obtained by the production method
08/25/2010CN101815535A molecules for targeting compounds to various selected organs or tissues
08/25/2010CN101815529A Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
08/25/2010CN101815510A Pharmaceutical preparations containing highly volatile silicones
08/25/2010CN101815508A non-aggregating virus formulation
08/25/2010CN101815507A Micro-particles, blood-substitute and method for forming same
08/25/2010CN101812227A Micelle based on non-linear polyethylene glycol-polylactic acid block copolymer and preparation method thereof
08/25/2010CN101812178A Reduction sensitive polyethyleneimine derivative as well as preparation method and application thereof
08/25/2010CN101812177A Preparations of cationic polymer modified by steroid hormone and gene composite thereof
08/25/2010CN101812157A Synthesis method of polymeric (N-isopropyl acrylamide)/attapulgite composite hydrogel
08/25/2010CN101812134A Antibodies that bind cell-associated ca 125/0722p and methods of use thereof
08/25/2010CN101810864A Preparation method of volatile oil beta-cyclodextrin inclusion compound
08/25/2010CN101810863A Preparation method of carboxymethyl chitosan quaternary ammonium salt/organic rectorite nano composite material and application thereof
08/25/2010CN101810862A Tanshinone IIA oral administration polymer micelle composition
08/25/2010CN101810861A Liquid preparation for preventing and curing mucous membrane and skin inflammation
08/25/2010CN101810855A II-type collagen joint cartilage fluid and preparation method thereof
08/25/2010CN101810854A Novel albumin-free factor VIII formulations
08/25/2010CN101810842A Method for preparing puerariae decoction particles
08/25/2010CN101810714A Sugar-free almond perilla anti-cough granules and preparation method thereof
08/25/2010CN101810666A Veterinary synergic enrofloxacin injection and preparation method thereof
08/25/2010CN101810660A Water-soluble silymarin and preparation method thereof
08/25/2010CN101810630A Fructose diphosphate sodium pharmaceutical composition injection and preparation method thereof
08/25/2010CN101810623A Ceftazidime medicinal composition for injection and preparation method thereof
08/25/2010CN101810620A Methionine-vitamin B1 composite injection and preparation method thereof
08/25/2010CN101810617A Preparation method and quality test method of pseudoephedrine hydrochloride and dextromethorphan hydrobromide chewable tablets
08/25/2010CN101810615A Azatadine-containing composition
08/25/2010CN101810611A Cyclodextrin inclusion compound of prasugrel and acid addition salt thereof and preparation method thereof
08/25/2010CN101810605A Salvianic acid A pharmaceutical composition and preparation method thereof
08/25/2010CN101810596A Controlled release transdermal patch for preventing and treating cardiovascular and cerebrovascular system diseases and preparation method thereof
08/25/2010CN101810595A Preparation method of calcium alginate microcapsule
08/25/2010CN101810594A Production method of silybin meglumine tablets
1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 1712